FRANKLIN, Tenn.--(BUSINESS WIRE)--Verici Dx, (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced that collaborators will present new data on the predictive performance of its TutiviaTM test at the American Transplant Congress (ATC) Annual Meeting, taking place June 20–24, 2026 in Boston. The abstracts are available via the planner on the ATC website. The two poster presentations, delivered by leading transplant clinicians, describe the ability of Tutiv